Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214330 · ClinicalTrials.gov registry record · NA
Clinician-Collected Versus Patient-Collected Cervical Pap Smears
A NA study, sponsored by Mike O'Callaghan Military Hospital.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT01214330 is a NA study that has completed, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 150 participants.
The verdict
NCT01214330, a NA study, has completed, sponsored by Mike O'Callaghan Military Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to see if it is possible to conduct a full study to determine whether the SoloPap™ cervical cell sample collection kit is as good as a clinician performed Pap test in detecting precancerous cervical lesions in females. Begin to determine patient attitudes regarding ease of use and discomfort using SoloPap.
Interventions
- DEVICE Patient-Collected Cervical Pap Smear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01214330
The ClinicalTrials.gov registry entry for NCT01214330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mike O'Callaghan Military Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patient-Collected Cervical Pap Smear is the first listed.
NCT01214330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01214330 about?
NCT01214330 is a clinical study titled "Clinician-Collected Versus Patient-Collected Cervical Pap Smears". The purpose of this study is to see if it is possible to conduct a full study to determine whether the SoloPap™ cervical cell sample collection kit is as good as a clinician performed Pap test in detecting precancerous cervical lesions in females. Begin to determine patient attitudes regarding ease...
What is the current status of trial NCT01214330?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2011-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01214330?
The interventions under investigation include: Patient-Collected Cervical Pap Smear (DEVICE).
Who is sponsoring clinical trial NCT01214330?
This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.